Bordeaux - CHU
Bordeaux - CHU
Bordeaux, France2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC) | Small Cell Lung Cancer Extensive Stage | Active, not recruiting | Phase 2 | 2026-08-11 | NCT05856695 | |
| Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS) | Non Small Cell Lung Cancer Metastatic | Active, not recruiting | Phase 2 | 2025-09-24 | NCT04621188 |